<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.0.0 (http://www.squarespace.com/) on Wed, 07 Jan 2009 01:16:37 GMT--><feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><title>Brain Imaging</title><subtitle>Brain Imaging</subtitle><id>http://brainscienceblogs.com/brain-imaging/</id><link rel="alternate" type="application/xhtml+xml" href="http://brainscienceblogs.com/brain-imaging/"/><link rel="self" type="application/atom+xml" href="http://brainscienceblogs.com/brain-imaging/atom.xml"/><updated>2008-03-25T22:21:13Z</updated><generator uri="http://www.squarespace.com/" version="Squarespace Site Server v5.0.0 (http://www.squarespace.com/)">Squarespace</generator><entry><title>Brain Imaging</title><category>Brain Imaging</category><id>http://brainscienceblogs.com/brain-imaging/2008/3/25/brain-imaging.html</id><link rel="alternate" type="text/html" href="http://brainscienceblogs.com/brain-imaging/2008/3/25/brain-imaging.html"/><author><name>Contacts</name></author><published>2008-03-25T21:40:47Z</published><updated>2008-03-25T21:40:47Z</updated><content type="html" xml:lang="en-US"><![CDATA[<p><a target="_blank" href="http://www.medworksmedia.com/psychopharmbulletin/index.php">The Revised Dopamine Hypothesis of Schizophrenia: Evidence from Pharmacological MRI Studies with Atypical Antipsychotic Medication<br />By Fabiana da Silva Alves, MS, Martijn Figee, MD, Therese van Amelsvoort, MD, PhD, Dick Veltman, MD, PhD, and Lieuwe de Haan, MD, PhD</a></p><p><a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=22" target="_blank">Fear, Anxiety, and the Neuroimaging of PTSD<br />By Eileen P. Ahearn, MD, PhD, Timothy Juergens, MD, Tracey Smith, PhD, Dean Krahn, MD, MS, and Ned Kalin, MD <br /></a></p><a target="_blank" href="http://www.medworksmedia.com/psychopharmbulletin/index.php"></a>
]]></content></entry></feed>